{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T12:04:11Z","timestamp":1781006651524,"version":"3.54.1"},"posted":{"date-parts":[[2026,6,5]]},"group-title":"Pharmacology and Toxicology","reference-count":75,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"NIH\/NIAID","award":["R56 AI173955"],"award-info":[{"award-number":["R56 AI173955"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,6,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>\n                  Herpes simplex virus-1 (HSV-1) UL12 gene encodes a well-conserved 5\u2019 \u2192 3\u2019 alkaline exonuclease. UL12 collaborates with the HSV single-strand DNA binding protein ICP8 to mediate recombination-dependent replication of viral DNA and is essential for the production of DNA that can be packaged into infectious virus. The UL12 gene has orthologs in the eight other human herpesviruses, including UL98 in HCMV and SOX in KSHV, which are also essential for virus production. We have developed viral nuclease inhibitors (VNIs) of HSV-1 UL12 that potently block its nuclease activity and display strong antiviral effects in cell culture. These inhibitors are also effective against alkaline nucleases from the \u03b2-HHV HCMV (UL98) and the \u03b3-HHV KSHV (SOX), and we have demonstrated antiviral activity against HSV-1 and HCMV in cell culture. In this work, we describe the first crystal structure of an alphaherpesvirus alkaline nuclease (UL12.5), which was used to elucidate structure activity relationships and improve the selectivity of our inhibitors. These VNIs exhibit EC\n                  <jats:sub>50<\/jats:sub>\n                  and IC\n                  <jats:sub>50<\/jats:sub>\n                  values in the nanomolar to low micromolar range. Our findings highlight the potential of targeting HHV alkaline nucleases with novel small molecules, paving the way for the development of new therapies that can be broadly antiviral on their own or in combination with nucleoside analogs.\n                <\/jats:p>\n                <jats:sec>\n                  <jats:title>Significance Statement<\/jats:title>\n                  <jats:p>Herpesviruses are widespread pathogens that establish lifelong infections and cause serious disease in immunocompromised individuals, neonates and older adults, yet treatment options remain limited. We report the first crystal structure of the HSV-1 alkaline nuclease UL12.5 and use it to design potent small-molecule inhibitors. These inhibitors exhibit antiviral activity against HSV-1 and HCMV, supporting alkaline nuclease as a conserved and druggable target across all herpesvirus subfamilies. The significance is threefold: it confirms alkaline nucleases as having an essential role in viral replication, provides a structural foundation for rational antiviral design and introduces a new class of inhibitors with potential as pan-herpesvirus therapeutics, alone or in combination, to overcome resistance and improve clinical outcomes.<\/jats:p>\n                <\/jats:sec>","DOI":"10.64898\/2026.06.03.729350","type":"posted-content","created":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T10:40:13Z","timestamp":1780742413000},"source":"Crossref","is-referenced-by-count":0,"title":["Viral Nuclease Inhibitors: Small molecule disruptors of the UL12 alkaline nuclease display broad anti-herpes virus activity"],"prefix":"10.64898","author":[{"given":"Nidhi","family":"Sharma","sequence":"first","affiliation":[{"name":"Department of Molecular Biology and Biophysics, University of Connecticut School of Medicine, Farmington, Connecticut, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyun","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, University of Connecticut School of Pharmacy, Storrs, Connecticut, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Szczepaniak","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology and Biophysics, University of Connecticut School of Medicine, Farmington, Connecticut, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chitra","family":"Rani","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology and Biophysics, University of Connecticut School of Medicine, Farmington, Connecticut, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheida Khojasteh","family":"Khosro","sequence":"additional","affiliation":[{"name":"Department of Chemistry, University of Connecticut School of Pharmacy, Storrs, Connecticut, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolanta","family":"Krucinska","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, University of Connecticut School of Pharmacy, Storrs, Connecticut, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, University of Connecticut School of Pharmacy, Storrs, Connecticut, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dung","family":"Do","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, University of Connecticut School of Pharmacy, Storrs, Connecticut, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Wright","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, University of Connecticut School of Pharmacy, Storrs, Connecticut, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Wright","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, University of Connecticut School of Pharmacy, Storrs, Connecticut, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Weller","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology and Biophysics, University of Connecticut School of Medicine, Farmington, Connecticut, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"key":"2026060904350880000_2026.06.03.729350v1.1","unstructured":"World Health Organization (WHO) (2024) Over 1 in 5 adults worldwide has a genital herpes infection \u2013 WHO, [online] https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/herpes-simplex-virus (Accessed January 1, 2025)"},{"key":"2026060904350880000_2026.06.03.729350v1.2","doi-asserted-by":"publisher","DOI":"10.2471\/BLT.19.237149"},{"key":"2026060904350880000_2026.06.03.729350v1.3","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2024-056307"},{"key":"2026060904350880000_2026.06.03.729350v1.4","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(82)90055-9"},{"key":"2026060904350880000_2026.06.03.729350v1.5","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/12.suppl_A.9"},{"key":"2026060904350880000_2026.06.03.729350v1.6","unstructured":"U.S. Food and Drug Administration (1982) ZOVIRAX (acyclovir) \u2013 injectable; NDA Original Approval. , Silver Spring, MD"},{"key":"2026060904350880000_2026.06.03.729350v1.7","unstructured":"U.S. Food and Drug Administration (1995) Drug Approval Package: Valtrex (valacyclovir hydrochloride) NDA 020487, Silver Spring, MD"},{"key":"2026060904350880000_2026.06.03.729350v1.8","unstructured":"U.S. Food and Drug Administration (1989) Ganciclovir Injection \u2013 original NDA approval., Silver Spring, MD"},{"key":"2026060904350880000_2026.06.03.729350v1.9","unstructured":"U.S. Food and Drug Administration (2001) Valcyte (valganciclovir hydrochloride) \u2013 original NDA approval., Silver Spring, MD"},{"key":"2026060904350880000_2026.06.03.729350v1.10","doi-asserted-by":"crossref","unstructured":"Mcintosh, M. , Hauschild, B. , and Miller, V. (2016) Human cytomegalovirus and transplantation: drug development and regulatory issues","DOI":"10.1016\/S2055-6640(20)30457-X"},{"key":"2026060904350880000_2026.06.03.729350v1.11","doi-asserted-by":"crossref","unstructured":"Van Der Wekken-Pas, L. C. , Tott\u00e9, J. , Lunel, F. V , Van Zuilen, A. , and Van Luin, M. (2023) Therapeutic Drug Monitoring of Ganciclovir in Cytomegalovirus-Infected Patients With Solid Organ Transplants and Its Correlation to Efficacy and Toxicity","DOI":"10.1097\/FTD.0000000000001054"},{"key":"2026060904350880000_2026.06.03.729350v1.12","unstructured":"U.S. Food and Drug Administration (2017) Prevymis (letermovir) \u2013 original NDA approval, Silver Spring MD"},{"key":"2026060904350880000_2026.06.03.729350v1.13","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1093\/jac\/dkaf063","article-title":"Drug\u2013drug interaction between letermovir and ciclosporin in allogeneic haematopoietic cell transplantation recipients","volume":"80","year":"2025","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"2026060904350880000_2026.06.03.729350v1.14","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1093\/infdis\/jiz578","article-title":"Letermovir resistance in hematopoietic stem cell transplant recipients: The risks associated with cytomegalovirus prophylaxis","volume":"221","year":"2020","journal-title":"Journal of Infectious Diseases"},{"key":"2026060904350880000_2026.06.03.729350v1.15","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01623-15"},{"key":"2026060904350880000_2026.06.03.729350v1.16","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz577"},{"key":"2026060904350880000_2026.06.03.729350v1.17","doi-asserted-by":"crossref","first-page":"3557","DOI":"10.1016\/S0021-9258(17)34837-8","article-title":"The Deoxyribonuclease Induced after Infection of KB Cells by Herpes Simplex Virus Type 1 or Type 2 I. Purification and Characterization of the Enzyme","volume":"253","year":"1978","journal-title":"J. Biol. Chem"},{"key":"2026060904350880000_2026.06.03.729350v1.18","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/17.19.7609"},{"key":"2026060904350880000_2026.06.03.729350v1.19","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1995.1203"},{"key":"2026060904350880000_2026.06.03.729350v1.20","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1128\/jvi.64.1.96-104.1990","article-title":"Purification and Properties of Epstein-Barr Virus DNase Expressed in Escherichia coli","volume":"64","year":"1990","journal-title":"J. Virol"},{"key":"2026060904350880000_2026.06.03.729350v1.21","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-78-11-2953"},{"key":"2026060904350880000_2026.06.03.729350v1.22","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1998.9344"},{"key":"2026060904350880000_2026.06.03.729350v1.23","doi-asserted-by":"crossref","first-page":"12396","DOI":"10.1073\/pnas.1635160100","article-title":"Functional map of human cytomegalovirus AD169 defined by global mutational analysis","volume":"100","year":"2003","journal-title":"Proc Natl Acad Sci PNAS"},{"key":"2026060904350880000_2026.06.03.729350v1.24","doi-asserted-by":"crossref","first-page":"4952","DOI":"10.1128\/JVI.00170-09","article-title":"The Epstein-Barr Virus Alkaline Exonuclease BGLF5 Serves Pleiotropic Functions in Virus Replication","volume":"83","year":"2009","journal-title":"J of Virology"},{"key":"2026060904350880000_2026.06.03.729350v1.25","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkac1190"},{"key":"2026060904350880000_2026.06.03.729350v1.26","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01380-17"},{"key":"2026060904350880000_2026.06.03.729350v1.27","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1146\/annurev-micro-091313-103424","article-title":"Recombination promoted by DNA viruses: Phage \u03bb to herpes simplex virus","volume":"68","year":"2014","journal-title":"Annu. Rev. Microbiol"},{"key":"2026060904350880000_2026.06.03.729350v1.28","doi-asserted-by":"crossref","first-page":"7425","DOI":"10.1128\/JVI.77.13.7425-7433.2003","article-title":"The Herpes Simplex Virus Type 1 Alkaline Nuclease and Single-Stranded DNA Binding Protein Mediate Strand Exchange In Vitro","volume":"77","year":"2003","journal-title":"J of Virology"},{"key":"2026060904350880000_2026.06.03.729350v1.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2004.07.012"},{"key":"2026060904350880000_2026.06.03.729350v1.30","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01836-24"},{"key":"2026060904350880000_2026.06.03.729350v1.31","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.70.4.2075-2085.1996"},{"key":"2026060904350880000_2026.06.03.729350v1.32","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02087-08"},{"key":"2026060904350880000_2026.06.03.729350v1.33","first-page":"e03226","article-title":"Two-Metal Ion-Dependent Enzymes as Potential Antiviral Targets in Human Herpesviruses Running","volume":"13","year":"2022","journal-title":"mBio"},{"key":"2026060904350880000_2026.06.03.729350v1.34","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.14.6498"},{"key":"2026060904350880000_2026.06.03.729350v1.35","doi-asserted-by":"publisher","DOI":"10.1017\/S0033583510000181"},{"key":"2026060904350880000_2026.06.03.729350v1.36","doi-asserted-by":"publisher","DOI":"10.3851\/IMP2690"},{"key":"2026060904350880000_2026.06.03.729350v1.37","doi-asserted-by":"publisher","DOI":"10.1124\/mol.105.020321"},{"key":"2026060904350880000_2026.06.03.729350v1.38","doi-asserted-by":"publisher","DOI":"10.1186\/2047-783x-14-s3-5"},{"key":"2026060904350880000_2026.06.03.729350v1.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2009.11.004"},{"key":"2026060904350880000_2026.06.03.729350v1.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2009.06.034"},{"key":"2026060904350880000_2026.06.03.729350v1.41","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-4658.2009.07374.x"},{"key":"2026060904350880000_2026.06.03.729350v1.42","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkr111"},{"key":"2026060904350880000_2026.06.03.729350v1.43","first-page":"4756","article-title":"KSHV SOX mediated host shutoff: the molecular mechanism underlying mRNA transcript processing","volume":"45","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"2026060904350880000_2026.06.03.729350v1.44","doi-asserted-by":"publisher","DOI":"10.1038\/S41586-021-03819-2"},{"key":"2026060904350880000_2026.06.03.729350v1.45","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-4658.2009.07374.x"},{"key":"2026060904350880000_2026.06.03.729350v1.46","doi-asserted-by":"publisher","DOI":"10.1126\/science.277.5333.1824"},{"key":"2026060904350880000_2026.06.03.729350v1.47","first-page":"7893","article-title":"Structural, functional, and evolutionary relationships between lambda-exonuclease and the type II restriction endonucleases","volume":"95","year":"1998","journal-title":"Biochemistry"},{"key":"2026060904350880000_2026.06.03.729350v1.48","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1103467108"},{"key":"2026060904350880000_2026.06.03.729350v1.49","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1140\/epje\/i2013-13005-4","article-title":"Characterization of void space in polydisperse sphere packings: Applications to hard-sphere packings and to protein structure analysis","volume":"36","year":"2013","journal-title":"The European Physical Journal E"},{"key":"2026060904350880000_2026.06.03.729350v1.50","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jctc.1c00302"},{"key":"2026060904350880000_2026.06.03.729350v1.51","doi-asserted-by":"publisher","DOI":"10.1021\/ci800324m"},{"key":"2026060904350880000_2026.06.03.729350v1.52","doi-asserted-by":"publisher","DOI":"10.1021\/jm051256o"},{"key":"2026060904350880000_2026.06.03.729350v1.53","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01634-14"},{"key":"2026060904350880000_2026.06.03.729350v1.54","unstructured":"Cheng, Y.-C. , and Prusoff, W. H . (1973) Relationship Between The Inhibition Constant (&) And The Concentration Of Inhibitor Which Causes 50 Per Cent Inhibition (Iso) Of An Enzymatic Reaction*, Pergamon Press"},{"key":"2026060904350880000_2026.06.03.729350v1.55","doi-asserted-by":"publisher","DOI":"10.1089\/adt.2011.0380"},{"key":"2026060904350880000_2026.06.03.729350v1.56","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.molstruc.2014.03.009","article-title":"MicroScale Thermophoresis: Interaction analysis and beyond","volume":"1077","year":"2014","journal-title":"J. Mol. Struct"},{"key":"2026060904350880000_2026.06.03.729350v1.57","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA120.016571"},{"key":"2026060904350880000_2026.06.03.729350v1.58","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02501-15"},{"key":"2026060904350880000_2026.06.03.729350v1.59","doi-asserted-by":"publisher","DOI":"10.3390\/v13020205"},{"key":"2026060904350880000_2026.06.03.729350v1.60","doi-asserted-by":"publisher","DOI":"10.1021\/jm3012068"},{"key":"2026060904350880000_2026.06.03.729350v1.61","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002862"},{"key":"2026060904350880000_2026.06.03.729350v1.62","first-page":"49","article-title":"Mining DNA sequences for molecular enzymology: The Red alpha superfamily defines a set of recombination nucleases","volume":"38","year":"1998","journal-title":"Proceedings of the 1998 Miami Nature Biotechnology Winter Symposium"},{"key":"2026060904350880000_2026.06.03.729350v1.63","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-3-8"},{"key":"2026060904350880000_2026.06.03.729350v1.64","doi-asserted-by":"publisher","DOI":"10.1107\/S0907444909047337"},{"key":"2026060904350880000_2026.06.03.729350v1.65","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1107\/S0907444905036693","article-title":"Scaling and assessment of data quality","volume":"62","year":"2006","journal-title":"Acta Chrystallogr D"},{"key":"2026060904350880000_2026.06.03.729350v1.66","doi-asserted-by":"publisher","DOI":"10.1107\/S0907444913000061"},{"key":"2026060904350880000_2026.06.03.729350v1.67","doi-asserted-by":"publisher","DOI":"10.1107\/S0021889807021206"},{"key":"2026060904350880000_2026.06.03.729350v1.68","doi-asserted-by":"publisher","DOI":"10.1107\/S2059798323003595"},{"key":"2026060904350880000_2026.06.03.729350v1.69","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-54668-2"},{"key":"2026060904350880000_2026.06.03.729350v1.70","first-page":"1","article-title":"Implications of AlphaFold2 for crystallographic phasing by molecular replacement","volume":"78","year":"2022","journal-title":"Acta Crystallogr. D Struct. Biol"},{"key":"2026060904350880000_2026.06.03.729350v1.71","doi-asserted-by":"publisher","DOI":"10.1107\/S0907444910007493"},{"key":"2026060904350880000_2026.06.03.729350v1.72","doi-asserted-by":"publisher","DOI":"10.1107\/S0907444996012255"},{"key":"2026060904350880000_2026.06.03.729350v1.73","doi-asserted-by":"crossref","first-page":"1000619","DOI":"10.1371\/journal.ppat.1000619","article-title":"Virus-Induced Chaperone-Enriched (VICE) Domains Function as Nuclear Protein Quality Control Centers during HSV-1 Infection","volume":"5","year":"2009","journal-title":"PLoS Pathog"},{"key":"2026060904350880000_2026.06.03.729350v1.74","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkae241"},{"key":"2026060904350880000_2026.06.03.729350v1.75","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkg556"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.64898\/2026.06.03.729350","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T11:35:36Z","timestamp":1781004936000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.64898\/2026.06.03.729350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,5]]},"references-count":75,"URL":"https:\/\/doi.org\/10.64898\/2026.06.03.729350","relation":{},"subject":[],"published":{"date-parts":[[2026,6,5]]},"subtype":"preprint"}}